Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for trans individuals is effective and generally safe in the short term.

Cross-sex hormone treatment in transsexual individuals helps understand how sex hormones affect diseases like heart disease and diabetes.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Insulin resistance is strongly linked to higher androgen levels in women with PCOS.

Men with COVID-19 have different hormone levels linked to disease severity.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Care for gender-dysphoric Veterans can be improved with a consistent, team-based approach.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Older men with lower levels of available testosterone are more likely to be frail.

Lower 2D:4D finger ratios in HS patients suggest prenatal hormone influence on the disease.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Phoenixin levels are higher in PCOS patients and may help in diagnosis.

Women with PCOS have different hormone levels than those without it.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Men's hair loss is not linked to their sex hormone levels, except for lower DHEAS in those with hair loss.